Beech Augusta, Singh Dave
Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
Medicines Evaluation Unit, Manchester University NHS Foundation Trust, Manchester, UK.
ERJ Open Res. 2022 Nov 28;8(4). doi: 10.1183/23120541.00246-2022. eCollection 2022 Oct.
A threshold of ∼60% has commonly been used in asthma and COPD studies to define the presence of neutrophilic airway inflammation. This threshold is based on relatively young healthy subject datasets. However, age-related increases in sputum neutrophils have been observed previously. We used a healthy cohort, with a comparatively wider age range, to re-evaluate the age-related increase in sputum neutrophils, analysing changes by decade. We also studied the long-term repeatability of sputum neutrophil counts. Differential sputum cell count data for healthy subjects (n=121) was retrospectively analysed. Subjects with a repeated count (mean interval 4.8 years) were included in longitudinal analysis. There was a significant positive association between age and sputum neutrophil % (rho=0.24, p<0.01), with 51.2% of subjects having a sputum neutrophil count >60%. Sputum neutrophil counts increased with each decade until ∼60 years where a plateau was observed. The baseline sputum neutrophil % increased significantly at repeated sampling (p=0.02), with excellent long-term repeatability (intraclass correlation coefficient=0.80). We confirm previous reports of an age-related increase in sputum neutrophil % in healthy individuals and identified a plateau which occurs at age ∼60 years. There was an increase in sputum neutrophil % during longitudinal follow-up, indicating that age-related neutrophilia is a progressive phenomenon. These findings question the use of an unadjusted threshold, in relation to age, to identify the presence of neutrophilic airway inflammation.
在哮喘和慢性阻塞性肺疾病(COPD)研究中,通常使用约60%的阈值来定义中性粒细胞气道炎症的存在。该阈值基于相对年轻的健康受试者数据集。然而,此前已观察到痰液中性粒细胞会随年龄增长而增加。我们使用了一个年龄范围相对更广的健康队列,按十年为单位分析变化,以重新评估痰液中性粒细胞随年龄的增长情况。我们还研究了痰液中性粒细胞计数的长期可重复性。对121名健康受试者的痰液细胞分类计数数据进行了回顾性分析。纵向分析纳入了重复计数(平均间隔4.8年)的受试者。年龄与痰液中性粒细胞百分比之间存在显著正相关(rho = 0.24,p < 0.01),51.2%的受试者痰液中性粒细胞计数>60%。痰液中性粒细胞计数随每十年增加,直至约60岁时出现平稳期。重复采样时基线痰液中性粒细胞百分比显著增加(p = 0.02),具有出色的长期可重复性(组内相关系数 = 0.80)。我们证实了之前关于健康个体痰液中性粒细胞百分比随年龄增加的报道,并确定了在约60岁时出现的平稳期。纵向随访期间痰液中性粒细胞百分比增加,表明年龄相关的嗜中性粒细胞增多是一种渐进性现象。这些发现对使用与年龄无关的未调整阈值来确定中性粒细胞气道炎症的存在提出了质疑。